Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis (Q37406532)

20 August 2017

0 references

1 reference

title

Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis (English)

1 reference

polycystic ovary syndrome

20 August 2017

0 references

1 reference

1 reference

1 reference

K A Toulis

1

1 reference

20 August 2017

D G Goulis

2

1 reference

20 August 2017

D Farmakiotis

3

1 reference

20 August 2017

N A Georgopoulos

4

1 reference

20 August 2017

I Katsikis

5

1 reference

20 August 2017

B C Tarlatzis

6

1 reference

20 August 2017

I Papadimas

7

1 reference

20 August 2017

D Panidis

8

1 reference

20 August 2017

4 March 2009

1 reference

Human Reproduction Update

20 August 2017

1 reference

20 August 2017

15

1 reference

20 August 2017

297-307

1 reference

20 August 2017

3

1 reference

Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome

20 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Endothelial function varies according to insulin resistance disease type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Evidence for altered adipocyte function in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Endothelial dysfunction in PCOS: role of obesity and adipose hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Meta-analysis. Beyond the grand mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Language bias in randomised controlled trials published in English and German.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Genetic determinants of insulin action in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Assessment of insulin resistance in young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Decreased plasma adiponectin concentrations in women with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Serum adiponectin levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Some comments on frequently used multiple endpoint adjustment methods in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Adiponectin--its role in metabolism and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Adjusting for publication bias in the presence of heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Determinants of circulating adiponectin in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Can adiponectin predict abnormal glucose tolerance in Thai women with polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Association of +45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

Factors contributing to the risk of cardiovascular disease reflected by plasma adiponectin: data from the coronary risk factors for atherosclerosis in women (CORA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP006

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMP006

1 reference

20 August 2017

1 reference